Position in NUVB
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$13,813,052
-$20,319,394 QoQ
Shares Held
3,219,826
-15.5% QoQ
Ownership
0.925%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. NUVB ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,813,052 | 3,219,826 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $34,132,446 | 3,809,425 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,327,897 | 629,162 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $408,799 | 209,641 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $181,918 | 103,363 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $471,439 | 177,233 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $615,940 | 268,970 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $945,089 | 323,661 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,329,786 | 365,326 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $729,284 | 482,970 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $319,024 | 238,079 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $482,928 | 268,294 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $842,370 | 507,452 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $585,956 | 305,186 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $457,963 | 204,448 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $433,378 | 133,759 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $265,135 | 50,406 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $437,418 | 51,461 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $160,012 | 16,098 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $348,211 | 37,402 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $449 | 43 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||